Managed Healthcare Executive April 17, 2024
Peter Wehrwein, Managing Editor

Adam Colborn outlined four trends in state-level action on pharmacy benefit managers (PBMs) and drugs in an interview prior to this presentation at the annual meeting of Academy of Managed Care Pharmacy (AMCP) today.

Although the spotlight has shifted to Congress and legislation it might pass concerning pharmacy benefit managers (PBMs), state legislatures and healthcare regulators are also enacting new laws and issuing new rules affecting the industry.

Adam Colborn, director, government affairs, of Academy of Managed Care Pharmacy (AMCP) discussed state-level developments today at presentation at AMCP’s annual meeting in New Orleans.

In an interview with Managed Healthcare Executive prior to the meeting, Colborn discussed four trends in state-level legislation and regulation: transparency, PBM spread pricing and rebate pass...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, States, Trends
STAT+: Eli Lilly raises earnings guidance as Zepbound sales beat expectations
From “Price Controls” To Robust Public Conversation: How CMS Can Move Drug Price Negotiation Into The Light
As demand for Adderall rises, officials fear a new drug crisis
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations

Share This Article